As Reported by the Committee on Health, Education, Labor, and Pensions on July 13, 2022
New From CBO
Estimated Direct Spending and Revenue Effects of S. 4348, the Food and Drug Administration Safety and Landmark Advancements Act of 2022
As Reported by the Committee on Health, Education, Labor, and Pensions on July 13, 2022
•
Email to a friend
•
